Serum leucine-rich alpha-2 glycoprotein in monitoring disease activity and intestinal mucosal healing for biotherapy-naïve cases with ulcerative colitis.

Masashi KonoYoriaki KomedaGeorge TriboniasSaki YoshidaKenji NomuraKohei HandaTomoyuki NagaiSatoru HagiwaraShunsuke OmotoMamoru TakenakaNaoshi NishidaNaoko TsujiHiroshi KashidaMasatoshi Kudo

Published in: JGH open : an open access journal of gastroenterology and hepatology (2023)

LRG was found to be the easiest marker to monitor disease activity and mucosal inflammation in UC patients with biotherapy-naïve cases, with a performance equivalent to that of Geboes scores.

Keyphrases

disease activity
ulcerative colitis

systemic lupus erythematosus
rheumatoid arthritis

rheumatoid arthritis patients
ankylosing spondylitis

juvenile idiopathic arthritis
oxidative stress